{"nct_id":"NCT04626518","title":"Substudy 03B: A Study of Immune and Targeted Combination Therapies in Participants With Second Line Plus (2L+) Renal Cell Carcinoma (MK-3475-03B/KEYMAKER-U03)","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-07","start_date":"2020-12-17","start_date_type":"ACTUAL","primary_completion_date":"2026-05-31","primary_completion_date_type":"ESTIMATED","completion_date":"2026-05-31","completion_date_type":"ESTIMATED","phases":["PHASE1","PHASE2"],"tickers":["MRK"]}